Ardent Health (ARDT) risk factors, FY2025 10-K

Risks Related to Our Business and Industry

1. 01Changes in government healthcare programs, including Medicare and Medicaid, could have an adverse effect on our revenues and business75% rewritten
2. 02or increase patient volumes covered by private third party payors and to maintain and obtain favorable contracts with private third party payors significantly affects our financial condition, results of operations and cash flowsNew
3. 03Our business may be adversely impacted by changes in healthcare laws, regulations, policies and government programsNew
4. 04Our hospitals, outpatient centers and other healthcare businesses operate in competitive environments, and competition in our markets may adversely affect patient volumes and other aspects of our business
5. 05Our performance depends on our ability to recruit and retain quality physicians
6. 06Our financial performance could be adversely affected by competition for staffing, the shortage of experienced nurses and other healthcare professionals, labor union activity and factors related to our employment of physicians
7. 07Changes to physician utilization practices and treatment methodologies and other factors outside our control that impact demand for medical services may reduce our revenues and ability to grow profitably
8. 08Third party payor controls designed to reduce costs and other payor practices intended to decrease inpatient services, surgical procedure volumes or reimbursement for services rendered may reduce our revenues
9. 09Industry trends towards value-based purchasing and care coordination among healthcare providers may present us with operational, financial and competitive challenges
10. 10We depend on key personnel, and losing one or more of our senior management team or local management personnel could have a material adverse effect on our business
11. 11We may not be able to successfully complete acquisitions or strategic JVs on acceptable terms, which may slow our growth rate
12. 12We may fail to realize all of the anticipated benefits of our past and any future acquisitions, or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating these acquired businesses into our operations
13. 13We may be subject to liabilities because of claims brought against our hospitals, physician practices, outpatient facilities or other business operations or against healthcare providers that provide services at our facilities
14. 14The failure to obtain our medical supplies and drugs at favorable prices or in sufficient volumes could cause our operating results to decline
15. 15We are subject to a variety of operational, legal and financial risks associated with outsourcing functions to third parties
16. 16Our facilities are heavily concentrated in Texas and Oklahoma, which makes us sensitive to regulatory, economic and competitive conditions and changes in those states66% rewritten
17. 17Our hospitals and other healthcare facilities may be negatively impacted by severe weather, climate change, and other factors beyond our control, which could restrict patient access to care or cause one or more of our facilities to close temporarily or permanently
18. 18We face certain risks related to the Ventas Master Lease, pursuant to which we lease ten of our hospitals and the associated Relative Rights Agreement
19. 19Our principal equity holders’ interests may conflict with yours45% rewritten
20. 20The agreements that govern our existing indebtedness impose significant operating and financial restrictions on us and our subsidiaries, which may prevent us from capitalizing on business opportunities, and we may be unable to refinance such indebtedness on acceptable terms
21. 21In addition, our ABL Facilities (as defined below) require us to maintain a minimum fixed charge coverage ratio if availability under our ABL Facilities falls below a certain threshold
22. 22Despite our current level of indebtedness, we may be able to incur substantially more debt and enter into other transactions which could further exacerbate the risks to our financial condition described above27% rewritten
23. 23A deterioration of public health conditions associated with a future pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise affects our facilities could adversely impact our business
24. 24The estimates of market opportunity and forecasts of market growth included in this report may prove to be inaccurate, and even if our addressable markets achieve the forecasted growth, our business could fail to grow at similar rates
25. 25Our cash and cash equivalents could be adversely affected if the financial institutions in which we hold our cash and cash equivalents fail

Risks Related to Regulation

1. 26If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations
2. 27Among these laws are the Stark Law, federal Anti-Kickback Statute, the FCA, the federal Civil Monetary Penalties Law, EMTALA, EKRA, HIPAA, CLIA and similar state laws40% rewritten
3. 28We may be the subject of government investigations, claims, audits, whistleblower and other litigation and payor audits
4. 29We are required to treat patients with emergency medical conditions regardless of ability to pay
5. 30Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations and financial condition
6. 31There are significant legal and regulatory restrictions on our hospitals that have physician owners
7. 32Tax matters, including disagreements with taxing authorities and imposition of new taxes, could impact our results of operations and financial condition
8. 33We incur substantial costs as a result of operating as a public company and our management is required to devote substantial time to new compliance initiatives and corporate governance practices of which we have limited experience
9. 34If we fail to maintain proper and effective internal control over financial reporting, our ability to produce accurate and timely financial statements could be impaired and investors’ views of us could be harmed

Risks Related to Technology

1. 35Healthcare technology initiatives, particularly those related to sharing patient data and interoperability, may adversely affect our operations
2. 36If we do not continually enhance our hospitals with the most recent technological advances in diagnostic and surgical equipment or obtain reimbursement from third party payors for the cost of such new technologies, our business and results of operations may be adversely affected
3. 37Our efforts to implement new technologies, including AI and machine learning, could have an adverse impact on our business, financial condition, results of operations, or growth plansNew

Risks Related to Ownership of our Common Stock

1. 38Our stock price could be volatile, and, as a result, our stockholders may not be able to resell their shares at or above the price paid for them28% rewritten
2. 39We are currently, and may in the future be, subject to securities litigation, which is expensive and could divert management’s time and attention from our business, and could have a material adverse effect on our results of operations, financial condition, prospects and stock priceNew
3. 40If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the price of our common stock may decline
4. 41We are a “controlled company” within the meaning of the rules of the NYSE and, as a result we rely on, exemptions from certain corporate governance requirements; you will not have the same protections afforded to stockholders of companies that are subject to all such requirements
5. 42Certain of our directors have relationships with our controlling stockholder, EGI-AM, and other affiliated entities of Equity Group Investments (“EGI”), which may cause conflicts of interest with respect to our business
6. 43Our certificate of incorporation contains a provision renouncing our interest and expectancy in certain corporate opportunities
7. 44Some provisions of Delaware law and our governing documents could discourage a takeover that stockholders may consider favorable
8. 45Future sales, or the perception of future sales, of our common stock may depress the price of our common stock85% rewritten
9. 46If securities or industry analysts do not publish research or publish misleading or unfavorable research about our business, our share price and trading volume may decline
10. 47We do not intend to pay cash dividends for the foreseeable future